{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T11:21:19Z","timestamp":1795173679605,"version":"4.10.3"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Alzheimer\u2019s disease (AD) is a fatal progressive neurodegenerative disease. Despite tremendous research efforts to understand this complex disease, the exact pathophysiology of the disease is not completely clear. Recently, anti-A\u03b2 antibodies have been shown to remove amyloid from the brain and slow the clinical progression of mild dementia by ~30%. However, exploring alternative strategies is crucial to understanding and developing more effective therapeutic interventions. In recent years, the microbiota-gut-brain axis has received significant attention in the AD field. Numerous studies have suggested that alterations in the gut microbiota composition are associated with the progression of AD, and several underlying mechanisms have been proposed. However, studies in this area are still in their infancy, and many aspects of this field are just beginning to be explored and understood. Gaining a deeper understanding of the intricate interactions and signaling pathways involved in the microbiota-AD interaction is crucial for optimizing therapeutic strategies targeting gut microbiota to positively impact AD. In this review, we aim to summarize the current understanding of the microbiota-gut-brain axis in AD. We will discuss the existing evidence regarding the role of gut microbiota in AD pathogenesis, suggested underlying mechanisms, biological factors influencing the microbiome-gut-brain axis in AD, and remaining questions in the field. Last, we will discuss potential therapeutic approaches to recondition the community of gut microbiota to alleviate disease progression. An ongoing exploration of the gut-brain axis and the development of microbiota-based therapies hold the potential for advancing AD management in the future.<\/jats:p>","DOI":"10.1038\/s12276-023-01146-2","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T21:02:13Z","timestamp":1704315733000},"page":"86-94","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":245,"title":["Current understanding of the Alzheimer\u2019s disease-associated microbiome and therapeutic strategies"],"prefix":"10.1038","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0315-4489","authenticated-orcid":false,"given":"Dong-oh","family":"Seo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Holtzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,4]]},"reference":[{"key":"1146_CR1","doi-asserted-by":"crossref","unstructured":"Long, J. & Holtzman, D. M. Alzheimer disease: an update on pathobiology and treatment strategies. Cell 179, 312\u2013339 (2019).","DOI":"10.1016\/j.cell.2019.09.001"},{"key":"1146_CR2","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1126\/science.abi6087","volume":"374","author":"G Agirman","year":"2021","unstructured":"Agirman, G., Yu, K. B. & Hsiao, E. Y. Signaling inflammation across the gut-brain axis. Science 374, 1087\u20131092 (2021).","journal-title":"Science"},{"key":"1146_CR3","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1093\/gerona\/glz262","volume":"75","author":"DO Seo","year":"2020","unstructured":"Seo, D. O. & Holtzman, D. M. Gut microbiota: from the forgotten organ to a potential key player in the pathology of Alzheimer\u2019s disease. J. Gerontol. A Biol. Sci. Med. Sci. 75, 1232\u20131241 (2020).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"1146_CR4","first-page":"1546267","volume":"30","author":"AM Moore","year":"2019","unstructured":"Moore, A. M., Mathias, M. & Valeur, J. Contextualising the microbiota-gut-brain axis in history and culture. Micro. Ecol. Health Dis. 30, 1546267 (2019).","journal-title":"Micro. Ecol. Health Dis."},{"key":"1146_CR5","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/bib\/bbz155","volume":"22","author":"R Bharti","year":"2021","unstructured":"Bharti, R. & Grimm, D. G. Current challenges and best-practice protocols for microbiome analysis. Brief. Bioinform. 22, 178\u2013193 (2021).","journal-title":"Brief. Bioinform."},{"key":"1146_CR6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neurobiolaging.2016.08.019","volume":"49","author":"A Cattaneo","year":"2017","unstructured":"Cattaneo, A. et al. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol. Aging 49, 60\u201368 (2017).","journal-title":"Neurobiol. Aging"},{"key":"1146_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13601-y","volume":"7","author":"NM Vogt","year":"2017","unstructured":"Vogt, N. M. et al. Gut microbiome alterations in Alzheimer\u2019s disease. Sci. Rep. 7, 13537 (2017).","journal-title":"Sci. Rep."},{"key":"1146_CR8","doi-asserted-by":"publisher","first-page":"e0285346","DOI":"10.1371\/journal.pone.0285346","volume":"18","author":"S Jemimah","year":"2023","unstructured":"Jemimah, S., Chabib, C. M. M., Hadjileontiadis, L. & AlShehhi, A. Gut microbiome dysbiosis in Alzheimer\u2019s disease and mild cognitive impairment: A systematic review and meta-analysis. PLoS ONE 18, e0285346 (2023).","journal-title":"PLoS ONE"},{"key":"1146_CR9","doi-asserted-by":"publisher","first-page":"eabo2984","DOI":"10.1126\/scitranslmed.abo2984","volume":"15","author":"AL Ferreiro","year":"2023","unstructured":"Ferreiro, A. L. et al. Gut microbiome composition may be an indicator of preclinical Alzheimer\u2019s disease. Sci. Transl. Med. 15, eabo2984 (2023).","journal-title":"Sci. Transl. Med"},{"key":"1146_CR10","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.3233\/JAD-180176","volume":"63","author":"ZQ Zhuang","year":"2018","unstructured":"Zhuang, Z. Q. et al. Gut microbiota is altered in patients with Alzheimer\u2019s disease. J. Alzheimers Dis. 63, 1337\u20131346 (2018).","journal-title":"J. Alzheimers Dis."},{"key":"1146_CR11","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3233\/JAD-160926","volume":"56","author":"C Brandscheid","year":"2017","unstructured":"Brandscheid, C. et al. Altered gut microbiome composition and tryptic activity of the 5xFAD Alzheimer\u2019s mouse model. J. Alzheimers Dis. 56, 775\u2013788 (2017).","journal-title":"J. Alzheimers Dis."},{"key":"1146_CR12","doi-asserted-by":"crossref","unstructured":"Chen, C. et al. Gut microbiota regulate Alzheimer\u2019s disease pathologies and cognitive disorders via PUFA-associated neuroinflammation. Gut 71, 2233-2252 (2022).","DOI":"10.1136\/gutjnl-2021-326269"},{"key":"1146_CR13","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3233\/JAD-181220","volume":"70","author":"BL Sun","year":"2019","unstructured":"Sun, B. L. et al. Gut microbiota alteration and its time course in a tauopathy mouse model. J. Alzheimers Dis. 70, 399\u2013412 (2019).","journal-title":"J. Alzheimers Dis."},{"key":"1146_CR14","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.jaci.2012.03.010","volume":"129","author":"LK Ursell","year":"2012","unstructured":"Ursell, L. K. et al. The interpersonal and intrapersonal diversity of human-associated microbiota in key body sites. J. Allergy Clin. Immunol. 129, 1204\u20131208 (2012).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1146_CR15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature11234","volume":"486","author":"MPC Human","year":"2012","unstructured":"Human, M. P. C. Structure, function and diversity of the healthy human microbiome. Nature 486, 207\u2013214 (2012).","journal-title":"Nature"},{"key":"1146_CR16","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nature07540","volume":"457","author":"PJ Turnbaugh","year":"2009","unstructured":"Turnbaugh, P. J. et al. A core gut microbiome in obese and lean twins. Nature 457, 480\u2013484 (2009).","journal-title":"Nature"},{"key":"1146_CR17","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nature11550","volume":"489","author":"CA Lozupone","year":"2012","unstructured":"Lozupone, C. A., Stombaugh, J. I., Gordon, J. I., Jansson, J. K. & Knight, R. Diversity, stability and resilience of the human gut microbiota. Nature 489, 220\u2013230 (2012).","journal-title":"Nature"},{"key":"1146_CR18","doi-asserted-by":"publisher","first-page":"14888","DOI":"10.1073\/pnas.1505587112","volume":"112","author":"I Fetzer","year":"2015","unstructured":"Fetzer, I. et al. The extent of functional redundancy changes as species\u2019 roles shift in different environments. Proc. Natl Acad. Sci. USA 112, 14888\u201314893 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1146_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/srep41802","volume":"7","author":"T Harach","year":"2017","unstructured":"Harach, T. et al. Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota. Sci. Rep. 7, 41802 (2017).","journal-title":"Sci. Rep."},{"key":"1146_CR20","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1084\/jem.20182386","volume":"216","author":"HB Dodiya","year":"2019","unstructured":"Dodiya, H. B. et al. Sex-specific effects of microbiome perturbations on cerebral A\u03b2 amyloidosis and microglia phenotypes. J. Exp. Med. 216, 1542\u20131560 (2019).","journal-title":"J. Exp. Med."},{"key":"1146_CR21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3389\/fnagi.2014.00066","volume":"6","author":"XL Wang","year":"2014","unstructured":"Wang, X. L. et al. Helicobacter pylori filtrate impairs spatial learning and memory in rats and increases \u03b2-amyloid by enhancing expression of presenilin-2. Front. Aging Neurosci. 6, 66 (2014).","journal-title":"Front. Aging Neurosci."},{"key":"1146_CR22","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1136\/gutjnl-2018-317431","volume":"69","author":"MS Kim","year":"2020","unstructured":"Kim, M. S. et al. Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer\u2019s disease animal model. Gut 69, 283\u2013294 (2020).","journal-title":"Gut"},{"key":"1146_CR23","doi-asserted-by":"publisher","first-page":"eadd1236","DOI":"10.1126\/science.add1236","volume":"379","author":"DO Seo","year":"2023","unstructured":"Seo, D. O. et al. ApoE isoform- and microbiota-dependent progression of neurodegeneration in a mouse model of tauopathy. Science 379, eadd1236 (2023).","journal-title":"Science"},{"key":"1146_CR24","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.chom.2013.03.010","volume":"13","author":"OO Koyuncu","year":"2013","unstructured":"Koyuncu, O. O., Hogue, I. B. & Enquist, L. W. Virus infections in the nervous system. Cell Host Microbe 13, 379\u2013393 (2013).","journal-title":"Cell Host Microbe"},{"key":"1146_CR25","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3233\/JAD-160152","volume":"51","author":"RF Itzhaki","year":"2016","unstructured":"Itzhaki, R. F. et al. Microbes and Alzheimer\u2019s disease. J. Alzheimers Dis. 51, 979\u2013984 (2016).","journal-title":"J. Alzheimers Dis."},{"key":"1146_CR26","doi-asserted-by":"publisher","first-page":"e1008596","DOI":"10.1371\/journal.ppat.1008596","volume":"16","author":"CE Seaks","year":"2020","unstructured":"Seaks, C. E. & Wilcock, D. M. Infectious hypothesis of Alzheimer disease. PLoS Pathog. 16, e1008596 (2020).","journal-title":"PLoS Pathog."},{"key":"1146_CR27","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.neuron.2018.05.023","volume":"99","author":"B Readhead","year":"2018","unstructured":"Readhead, B. et al. Multiscale analysis of independent Alzheimer\u2019s cohorts finds disruption of molecular, genetic, and clinical networks by human herpesvirus. Neuron 99, 64\u201382.e7 (2018).","journal-title":"Neuron"},{"key":"1146_CR28","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s13311-018-0611-x","volume":"15","author":"NS Tzeng","year":"2018","unstructured":"Tzeng, N. S. et al. Anti-herpetic medications and reduced risk of dementia in patients with herpes simplex virus infections\u2014a nationwide, population-based cohort study in Taiwan. Neurotherapeutics 15, 417\u2013429 (2018).","journal-title":"Neurotherapeutics"},{"key":"1146_CR29","doi-asserted-by":"publisher","first-page":"889","DOI":"10.3233\/JAD-215398","volume":"85","author":"AG Senejani","year":"2022","unstructured":"Senejani, A. G. et al. Borrelia burgdorferi Co-Localizing with Amyloid Markers in Alzheimer\u2019s Disease Brain Tissues. J. Alzheimers Dis. 85, 889\u2013903 (2022).","journal-title":"J. Alzheimers Dis."},{"key":"1146_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-06749-9","volume":"12","author":"A Chacko","year":"2022","unstructured":"Chacko, A. et al. Chlamydia pneumoniae can infect the central nervous system via the olfactory and trigeminal nerves and contributes to Alzheimer\u2019s disease risk. Sci. Rep. 12, 2759 (2022).","journal-title":"Sci. Rep."},{"key":"1146_CR31","doi-asserted-by":"publisher","first-page":"eaau3333","DOI":"10.1126\/sciadv.aau3333","volume":"5","author":"SS Dominy","year":"2019","unstructured":"Dominy, S. S. et al. Porphyromonas gingivalis in Alzheimer\u2019s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors. Sci. Adv. 5, eaau3333 (2019).","journal-title":"Sci. Adv."},{"key":"1146_CR32","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/j.jalz.2018.06.3040","volume":"14","author":"RD Moir","year":"2018","unstructured":"Moir, R. D., Lathe, R. & Tanzi, R. E. The antimicrobial protection hypothesis of Alzheimer\u2019s disease. Alzheimers Dement. 14, 1602\u20131614 (2018).","journal-title":"Alzheimers Dement."},{"key":"1146_CR33","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neuron.2018.06.030","volume":"99","author":"WA Eimer","year":"2018","unstructured":"Eimer, W. A. et al. Alzheimer\u2019s disease-associated \u03b2-amyloid is rapidly seeded by herpesviridae to protect against brain infection. Neuron 99, 56\u201363.e3 (2018).","journal-title":"Neuron"},{"key":"1146_CR34","volume":"10","author":"Y Wu","year":"2019","unstructured":"Wu, Y. et al. Microglia and amyloid precursor protein coordinate control of transient Candida cerebritis with memory deficits. Nat. Commun. 10, 685 (2019).","journal-title":"Nat. Commun."},{"key":"1146_CR35","doi-asserted-by":"publisher","unstructured":"Thapa, M. et al. Translocation of gut commensal bacteria to the brain. bioRxiv https:\/\/doi.org\/10.1101\/2023.08.30.555630 (2023).","DOI":"10.1101\/2023.08.30.555630"},{"key":"1146_CR36","doi-asserted-by":"publisher","first-page":"e1006654","DOI":"10.1371\/journal.ppat.1006654","volume":"13","author":"RP Friedland","year":"2017","unstructured":"Friedland, R. P. & Chapman, M. R. The role of microbial amyloid in neurodegeneration. PLoS Pathog. 13, e1006654 (2017).","journal-title":"PLoS Pathog."},{"key":"1146_CR37","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.1113\/JP280336","volume":"598","author":"KH Sch\u00e4fer","year":"2020","unstructured":"Sch\u00e4fer, K. H., Christmann, A. & Gries, M. Intra-gastrointestinal amyloid-\u03b21\u201342 oligomers perturb enteric function and induce Alzheimer\u2019s disease pathology. J. Physiol. 598, 4141\u20134142 (2020).","journal-title":"J. Physiol."},{"key":"1146_CR38","doi-asserted-by":"publisher","first-page":"2167172","DOI":"10.1080\/19490976.2023.2167172","volume":"15","author":"J Jin","year":"2023","unstructured":"Jin, J. et al. Gut-derived \u03b2-amyloid: Likely a centerpiece of the gut-brain axis contributing to Alzheimer\u2019s pathogenesis. Gut Microbes 15, 2167172 (2023).","journal-title":"Gut Microbes"},{"key":"1146_CR39","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s41577-018-0051-1","volume":"18","author":"Y Shi","year":"2018","unstructured":"Shi, Y. & Holtzman, D. M. Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight. Nat. Rev. Immunol. 18, 759\u2013772 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"1146_CR40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41583-022-00641-1","volume":"24","author":"AN Brandebura","year":"2023","unstructured":"Brandebura, A. N., Paumier, A., Onur, T. S. & Allen, N. J. Astrocyte contribution to dysfunction, risk and progression in neurodegenerative disorders. Nat. Rev. Neurosci. 24, 23\u201339 (2023).","journal-title":"Nat. Rev. Neurosci."},{"key":"1146_CR41","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/nn.4030","volume":"18","author":"D Erny","year":"2015","unstructured":"Erny, D. et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat. Neurosci. 18, 965\u2013977 (2015).","journal-title":"Nat. Neurosci."},{"key":"1146_CR42","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.cell.2017.11.042","volume":"172","author":"MS Thion","year":"2018","unstructured":"Thion, M. S. et al. Microbiome influences prenatal and adult microglia in a sex-specific manner. Cell 172, 500\u2013516.e16 (2018).","journal-title":"Cell"},{"key":"1146_CR43","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/glia.23277","volume":"66","author":"R Hanamsagar","year":"2018","unstructured":"Hanamsagar, R. et al. Generation of a microglial developmental index in mice and in humans reveals a sex difference in maturation and immune reactivity. Glia 66, 460 (2018).","journal-title":"Glia"},{"key":"1146_CR44","doi-asserted-by":"publisher","first-page":"aad8670","DOI":"10.1126\/science.aad8670","volume":"353","author":"O Matcovitch-Natan","year":"2016","unstructured":"Matcovitch-Natan, O. et al. Microglia development follows a stepwise program to regulate brain homeostasis. Science 353, aad8670 (2016).","journal-title":"Science"},{"key":"1146_CR45","doi-asserted-by":"publisher","first-page":"100318","DOI":"10.1016\/j.bbih.2021.100318","volume":"16","author":"S Spichak","year":"2021","unstructured":"Spichak, S. et al. Microbially-derived short-chain fatty acids impact astrocyte gene expression in a sex-specific manner. Brain Behav. Immun. Health 16, 100318 (2021).","journal-title":"Brain Behav. Immun. Health"},{"key":"1146_CR46","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1016\/j.cmet.2021.10.010","volume":"33","author":"D Erny","year":"2021","unstructured":"Erny, D. et al. Microbiota-derived acetate enables the metabolic fitness of the brain innate immune system during health and disease. Cell Metab. 33, 2260\u20132276.e7 (2021).","journal-title":"Cell Metab."},{"key":"1146_CR47","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s40478-020-00988-5","volume":"8","author":"C Mez\u00f6","year":"2020","unstructured":"Mez\u00f6, C. et al. Different effects of constitutive and induced microbiota modulation on microglia in a mouse model of Alzheimer\u2019s disease. Acta Neuropathol. Commun. 8, 119 (2020).","journal-title":"Acta Neuropathol. Commun."},{"key":"1146_CR48","doi-asserted-by":"crossref","unstructured":"Dodiya, H. B. et al. Gut microbiota-driven brain A\u03b2 amyloidosis in mice requires microglia. J. Exp. Med. 219, e20200895 (2022).","DOI":"10.1084\/jem.20200895"},{"key":"1146_CR49","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41392-022-00974-4","volume":"7","author":"K Hou","year":"2022","unstructured":"Hou, K. et al. Microbiota in health and diseases. Signal. Transduct. Target Ther. 7, 135 (2022).","journal-title":"Signal. Transduct. Target Ther."},{"key":"1146_CR50","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13195-023-01218-5","volume":"15","author":"M Marizzoni","year":"2023","unstructured":"Marizzoni, M. et al. A peripheral signature of Alzheimer\u2019s disease featuring microbiota-gut-brain axis markers. Alzheimers Res. Ther. 15, 101 (2023).","journal-title":"Alzheimers Res. Ther."},{"key":"1146_CR51","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41582-021-00549-x","volume":"17","author":"BM Bettcher","year":"2021","unstructured":"Bettcher, B. M., Tansey, M. G., Doroth\u00e9e, G. & Heneka, M. T. Peripheral and central immune system crosstalk in Alzheimer disease\u2014a research prospectus. Nat. Rev. Neurol. 17, 689\u2013701 (2021).","journal-title":"Nat. Rev. Neurol."},{"key":"1146_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/srep30028","volume":"6","author":"MR Minter","year":"2016","unstructured":"Minter, M. R. et al. Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer\u2019s disease. Sci. Rep. 6, 30028 (2016).","journal-title":"Sci. Rep."},{"key":"1146_CR53","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/acps.12698","volume":"135","author":"CA K\u00f6hler","year":"2017","unstructured":"K\u00f6hler, C. A. et al. Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta Psychiatr. Scand. 135, 373\u2013387 (2017).","journal-title":"Acta Psychiatr. Scand."},{"key":"1146_CR54","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nature11087","volume":"485","author":"RD Bell","year":"2012","unstructured":"Bell, R. D. et al. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 485, 512\u2013516 (2012).","journal-title":"Nature"},{"key":"1146_CR55","doi-asserted-by":"crossref","unstructured":"Montagne, A. et al. APOE4 accelerates advanced-stage vascular and neurodegenerative disorder in old Alzheimer\u2019s mice via cyclophilin A independently of amyloid-\u03b2. Nat. Aging 1, 506\u2013520 (2021).","DOI":"10.1038\/s43587-021-00073-z"},{"key":"1146_CR56","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/cdd.2010.117","volume":"18","author":"Y Tang","year":"2011","unstructured":"Tang, Y., Chen, Y., Jiang, H. & Nie, D. Short-chain fatty acids induced autophagy serves as an adaptive strategy for retarding mitochondria-mediated apoptotic cell death. Cell Death Differ. 18, 602\u2013618 (2011).","journal-title":"Cell Death Differ."},{"key":"1146_CR57","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1194\/jlr.R036012","volume":"54","author":"G den Besten","year":"2013","unstructured":"den Besten, G. et al. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J. Lipid Res. 54, 2325\u20132340 (2013).","journal-title":"J. Lipid Res."},{"key":"1146_CR58","doi-asserted-by":"publisher","first-page":"6926","DOI":"10.1523\/JNEUROSCI.0800-08.2008","volume":"28","author":"B Boland","year":"2008","unstructured":"Boland, B. et al. Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer\u2019s disease. J. Neurosci. 28, 6926\u20136937 (2008).","journal-title":"J. Neurosci."},{"key":"1146_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02587-2","volume":"7","author":"L Bonfili","year":"2017","unstructured":"Bonfili, L. et al. Microbiota modulation counteracts Alzheimer\u2019s disease progression influencing neuronal proteolysis and gut hormones plasma levels. Sci. Rep. 7, 2426 (2017).","journal-title":"Sci. Rep."},{"key":"1146_CR60","doi-asserted-by":"publisher","first-page":"102730","DOI":"10.1016\/j.conb.2023.102730","volume":"81","author":"H Choi","year":"2023","unstructured":"Choi, H. & Mook-Jung, I. Functional effects of gut microbiota-derived metabolites in Alzheimer\u2019s disease. Curr. Opin. Neurobiol. 81, 102730 (2023).","journal-title":"Curr. Opin. Neurobiol."},{"key":"1146_CR61","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","volume":"16","author":"B Dalile","year":"2019","unstructured":"Dalile, B., Van Oudenhove, L., Vervliet, B. & Verbeke, K. The role of short-chain fatty acids in microbiota-gut-brain communication. Nat. Rev. Gastroenterol. Hepatol. 16, 461\u2013478 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1146_CR62","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1126\/science.1241165","volume":"341","author":"PM Smith","year":"2013","unstructured":"Smith, P. M. et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341, 569\u2013573 (2013).","journal-title":"Science"},{"key":"1146_CR63","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nature12726","volume":"504","author":"N Arpaia","year":"2013","unstructured":"Arpaia, N. et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504, 451\u2013455 (2013).","journal-title":"Nature"},{"key":"1146_CR64","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1038\/s41590-020-0776-4","volume":"21","author":"K Alves de Lima","year":"2020","unstructured":"Alves de Lima, K. et al. Meningeal \u03b3\u03b4 T cells regulate anxiety-like behavior via IL-17a signaling in neurons. Nat. Immunol. 21, 1421\u20131429 (2020).","journal-title":"Nat. Immunol."},{"key":"1146_CR65","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.tim.2021.02.001","volume":"29","author":"B van der Hee","year":"2021","unstructured":"van der Hee, B. & Wells, J. M. Microbial regulation of host physiology by short-chain fatty acids. Trends Microbiol. 29, 700\u2013712 (2021).","journal-title":"Trends Microbiol."},{"key":"1146_CR66","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1523\/JNEUROSCI.1359-19.2019","volume":"40","author":"R Sadler","year":"2020","unstructured":"Sadler, R. et al. Short-chain fatty acids improve poststroke recovery via immunological mechanisms. J. Neurosci. 40, 1162\u20131173 (2020).","journal-title":"J. Neurosci."},{"key":"1146_CR67","doi-asserted-by":"publisher","first-page":"25311","DOI":"10.1073\/pnas.1905787116","volume":"116","author":"CE McMurran","year":"2019","unstructured":"McMurran, C. E. et al. The microbiota regulates murine inflammatory responses to toxin-induced CNS demyelination but has minimal impact on remyelination. Proc. Natl Acad. Sci. USA 116, 25311\u201325321 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1146_CR68","doi-asserted-by":"crossref","unstructured":"Abdel-Haq, R. et al. A prebiotic diet modulates microglial states and motor deficits in \u03b1-synuclein overexpressing mice. Elife 11, e81453 (2022).","DOI":"10.7554\/eLife.81453"},{"key":"1146_CR69","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3233\/JAD-190120","volume":"74","author":"WMADB Fernando","year":"2020","unstructured":"Fernando, W. M. A. D. B. et al. Sodium butyrate reduces brain amyloid-\u03b2 levels and improves cognitive memory performance in an Alzheimer\u2019s disease transgenic mouse model at an early disease stage. J. Alzheimers Dis. 74, 91\u201399 (2020).","journal-title":"J. Alzheimers Dis."},{"key":"1146_CR70","doi-asserted-by":"publisher","first-page":"109452","DOI":"10.1016\/j.cbi.2021.109452","volume":"341","author":"Y Jiang","year":"2021","unstructured":"Jiang, Y., Li, K., Li, X., Xu, L. & Yang, Z. Sodium butyrate ameliorates the impairment of synaptic plasticity by inhibiting the neuroinflammation in 5XFAD mice. Chem. Biol. Interact. 341, 109452 (2021).","journal-title":"Chem. Biol. Interact."},{"key":"1146_CR71","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1007\/s10571-022-01268-7","volume":"43","author":"D Cuervo-Zanatta","year":"2023","unstructured":"Cuervo-Zanatta, D. et al. Dietary fiber modulates the release of gut bacterial products preventing cognitive decline in an Alzheimer\u2019s mouse model. Cell Mol. Neurobiol. 43, 1595\u20131618 (2023).","journal-title":"Cell Mol. Neurobiol."},{"key":"1146_CR72","doi-asserted-by":"publisher","first-page":"580001","DOI":"10.3389\/fnagi.2020.580001","volume":"12","author":"J Killingsworth","year":"2020","unstructured":"Killingsworth, J., Sawmiller, D. & Shytle, R. D. Propionate and Alzheimer\u2019s disease. Front. Aging Neurosci. 12, 580001 (2020).","journal-title":"Front. Aging Neurosci."},{"key":"1146_CR73","doi-asserted-by":"publisher","first-page":"100138","DOI":"10.1016\/j.xcrm.2020.100138","volume":"1","author":"P Baloni","year":"2020","unstructured":"Baloni, P. et al. Metabolic network analysis reveals altered bile acid synthesis and metabolism in Alzheimer\u2019s disease. Cell Rep. Med. 1, 100138 (2020).","journal-title":"Cell Rep. Med."},{"key":"1146_CR74","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13024-022-00548-6","volume":"17","author":"E Connell","year":"2022","unstructured":"Connell, E. et al. Microbial-derived metabolites as a risk factor of age-related cognitive decline and dementia. Mol. Neurodegener. 17, 43 (2022).","journal-title":"Mol. Neurodegener."},{"key":"1146_CR75","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13195-018-0451-2","volume":"10","author":"NM Vogt","year":"2018","unstructured":"Vogt, N. M. et al. The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer\u2019s disease. Alzheimers Res. Ther. 10, 124 (2018).","journal-title":"Alzheimers Res. Ther."},{"key":"1146_CR76","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nature25979","volume":"555","author":"L Maier","year":"2018","unstructured":"Maier, L. et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 555, 623\u2013628 (2018).","journal-title":"Nature"},{"key":"1146_CR77","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nature25973","volume":"555","author":"D Rothschild","year":"2018","unstructured":"Rothschild, D. et al. Environment dominates over host genetics in shaping human gut microbiota. Nature 555, 210\u2013215 (2018).","journal-title":"Nature"},{"key":"1146_CR78","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3389\/fimmu.2020.00200","volume":"11","author":"IJ Parikh","year":"2020","unstructured":"Parikh, I. J. et al. Murine gut microbiome association with APOE alleles. Front. Immunol. 11, 200 (2020).","journal-title":"Front. Immunol."},{"key":"1146_CR79","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13024-019-0352-2","volume":"14","author":"J Maldonado Weng","year":"2019","unstructured":"Maldonado Weng, J. et al. Synergistic effects of APOE and sex on the gut microbiome of young EFAD transgenic mice. Mol. Neurodegener. 14, 47 (2019).","journal-title":"Mol. Neurodegener."},{"key":"1146_CR80","doi-asserted-by":"publisher","first-page":"8221","DOI":"10.1096\/fj.201900071R","volume":"33","author":"TTT Tran","year":"2019","unstructured":"Tran, T. T. T. et al. APOE genotype influences the gut microbiome structure and function in humans and mice: relevance for Alzheimer\u2019s disease pathophysiology. FASEB J. 33, 8221\u20138231 (2019).","journal-title":"FASEB J."},{"key":"1146_CR81","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.neurobiolaging.2007.11.014","volume":"30","author":"MP Vitek","year":"2009","unstructured":"Vitek, M. P., Brown, C. M. & Colton, C. A. APOE genotype-specific differences in the innate immune response. Neurobiol. Aging 30, 1350\u20131360 (2009).","journal-title":"Neurobiol. Aging"},{"key":"1146_CR82","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein, S. L. & Flanagan, K. L. Sex differences in immune responses. Nat. Rev. Immunol. 16, 626\u2013638 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"1146_CR83","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.neurobiolaging.2004.08.001","volume":"26","author":"CA Colton","year":"2005","unstructured":"Colton, C. A., Brown, C. M. & Vitek, M. P. Sex steroids, APOE genotype and the innate immune system. Neurobiol. Aging 26, 363\u2013372 (2005).","journal-title":"Neurobiol. Aging"},{"key":"1146_CR84","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/s41586-022-04427-4","volume":"603","author":"L Hosang","year":"2022","unstructured":"Hosang, L. et al. The lung microbiome regulates brain autoimmunity. Nature 603, 138\u2013144 (2022).","journal-title":"Nature"},{"key":"1146_CR85","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/s41422-019-0227-7","volume":"29","author":"DO Seo","year":"2019","unstructured":"Seo, D. O., Boros, B. D. & Holtzman, D. M. The microbiome: a target for Alzheimer disease. Cell Res. 29, 779\u2013780 (2019).","journal-title":"Cell Res"},{"key":"1146_CR86","first-page":"1543","volume":"6","author":"MP Francino","year":"2015","unstructured":"Francino, M. P. Antibiotics and the human gut microbiome: dysbioses and accumulation of resistances. Front. Microbiol. 6, 1543 (2015).","journal-title":"Front. Microbiol."},{"key":"1146_CR87","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.3233\/JAD-221153","volume":"93","author":"E Raku\u0161a","year":"2023","unstructured":"Raku\u0161a, E., Fink, A., Tamg\u00fcney, G., Heneka, M. T. & Doblhammer, G. Sporadic use of antibiotics in older adults and the risk of dementia: a nested case-control study based on German Health Claims Data. J. Alzheimers Dis. 93, 1329\u20131339 (2023).","journal-title":"J. Alzheimers Dis."},{"key":"1146_CR88","doi-asserted-by":"publisher","first-page":"300060520925930","DOI":"10.1177\/0300060520925930","volume":"48","author":"S Hazan","year":"2020","unstructured":"Hazan, S. Rapid improvement in Alzheimer\u2019s disease symptoms following fecal microbiota transplantation: a case report. J. Int. Med. Res. 48, 300060520925930 (2020).","journal-title":"J. Int. Med. Res."},{"key":"1146_CR89","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1080\/03007995.2021.1957807","volume":"37","author":"SH Park","year":"2021","unstructured":"Park, S. H. et al. Cognitive function improvement after fecal microbiota transplantation in Alzheimer\u2019s dementia patient: a case report. Curr. Med. Res. Opin. 37, 1739\u20131744 (2021).","journal-title":"Curr. Med. Res. Opin."},{"key":"1146_CR90","doi-asserted-by":"publisher","first-page":"6449","DOI":"10.18632\/aging.204230","volume":"14","author":"SH Park","year":"2022","unstructured":"Park, S. H. et al. Fecal microbiota transplantation can improve cognition in patients with cognitive decline and Clostridioides difficile infection. Aging (Albany NY) 14, 6449\u20136466 (2022).","journal-title":"Aging (Albany NY)"},{"key":"1146_CR91","doi-asserted-by":"publisher","first-page":"1032494","DOI":"10.3389\/fnagi.2022.1032494","volume":"14","author":"C Akhgarjand","year":"2022","unstructured":"Akhgarjand, C., Vahabi, Z., Shab-Bidar, S., Etesam, F. & Djafarian, K. Effects of probiotic supplements on cognition, anxiety, and physical activity in subjects with mild and moderate Alzheimer\u2019s disease: a randomized, double-blind, and placebo-controlled study. Front. Aging Neurosci. 14, 1032494 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"1146_CR92","doi-asserted-by":"publisher","first-page":"111959","DOI":"10.1016\/j.exger.2022.111959","volume":"170","author":"X He","year":"2022","unstructured":"He, X. et al. The preventive effects of probiotic Akkermansia muciniphila on D-galactose\/AlCl3 mediated Alzheimer\u2019s disease-like rats. Exp. Gerontol. 170, 111959 (2022).","journal-title":"Exp. Gerontol."},{"key":"1146_CR93","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.1021\/acs.jafc.3c00652","volume":"71","author":"G Zhu","year":"2023","unstructured":"Zhu, G., Zhao, J., Wang, G. & Chen, W. Bifidobacterium breve HNXY26M4 attenuates cognitive deficits and neuroinflammation by regulating the gut\u2013brain axis in APP\/PS1 mice. J. Agric. Food Chem. 71, 4646\u20134655 (2023).","journal-title":"J. Agric. Food Chem."},{"key":"1146_CR94","doi-asserted-by":"crossref","unstructured":"Bicknell, B. et al. Neurodegenerative and neurodevelopmental diseases and the gut-brain axis: the potential of therapeutic targeting of the microbiome. Int. J. Mol. Sci. 24, 9577 (2023).","DOI":"10.3390\/ijms24119577"},{"key":"1146_CR95","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.chom.2022.03.036","volume":"30","author":"SM Lancaster","year":"2022","unstructured":"Lancaster, S. M. et al. Global, distinctive, and personal changes in molecular and microbial profiles by specific fibers in humans. Cell Host Microbe 30, 848\u2013862.e7 (2022).","journal-title":"Cell Host Microbe"},{"key":"1146_CR96","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nature18846","volume":"535","author":"JL Sonnenburg","year":"2016","unstructured":"Sonnenburg, J. L. & B\u00e4ckhed, F. Diet-microbiota interactions as moderators of human metabolism. Nature 535, 56\u201364 (2016).","journal-title":"Nature"},{"key":"1146_CR97","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41422-019-0216-x","volume":"29","author":"X Wang","year":"2019","unstructured":"Wang, X. et al. Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer\u2019s disease progression. Cell Res. 29, 787\u2013803 (2019).","journal-title":"Cell Res"}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-023-01146-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-023-01146-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-023-01146-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T03:03:33Z","timestamp":1707361413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-023-01146-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,4]]},"references-count":97,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["1146"],"URL":"https:\/\/doi.org\/10.1038\/s12276-023-01146-2","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,4]]},"assertion":[{"value":"19 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.M.H. is a cofounder of C2N Diagnostics, LLC, and is on the scientific advisory board and\/or consults for Genentech, Denali, C2N Diagnostics, Cajal Neurosciences, and Asteroid. D.M.H. is an inventor on a patent licensed by Washington University to NextCure on the therapeutic use of anti-apoE antibodies. The Holtzman laboratory receives research grants from the National Institutes of Health, the Cure Alzheimer\u2019s Fund, the Rainwater Foundation, the JPB Foundation, the Good Ventures Foundation, the GHR Foundation, Novartis, Eli Lilly, and NextCure. The authors declare no other competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}